Oklo (OKLO) Q3 2024 earnings summary

Executive summary

• Achieved major regulatory, project, and customer milestones in Q3 2024, including new LOIs for up to 750 MW with data centers and a $25M prepayment from Equinix.

• Announced and signed a $25M all-stock term sheet to acquire Atomic Alchemy, expanding into radioisotope production and diversifying revenue streams.

• Completed business combination with AltC in May 2024, raising $276.2M gross and listing on NYSE.

• Maintained a well-capitalized balance sheet with $288.5M in cash and marketable securities at quarter-end.

• Customer agreements and pipeline now total over 2.1 GW, with strong demand from data centers, oil & gas, and other sectors.

Financial highlights

• Net loss for Q3 2024 was $9.96M; nine-month net loss was $63.3M, including $30M in non-cash FMV losses and $10.8M in stock-based compensation.

• Operating loss for the nine months ended September 30, 2024, was $37.4M, including a $7.8M one-time fair value adjustment for earn-out shares.

• Cash and marketable securities totaled $288.5M at quarter end, primarily from $276M in proceeds at deal closure.

• Net cash used in operating activities for nine months was $24.9M.

• Full-year 2024 operating loss expected to be $40M–$50M, in line with prior guidance.

Outlook and guidance

• Targeting first reactor online in late 2027, with groundbreaking at Idaho anticipated as soon as 2026.

• Full-year 2024 financial expectations remain in line with prior guidance.

• Focused on licensing, project execution, customer pipeline growth, and integration of radioisotope production.

• Existing liquidity expected to fund operations for at least one year post-report date.

• Expecting accelerated licensing for subsequent plants, potentially reducing review times to as little as seven months.